Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Carroll & O'Dea
This article focuses on some information provision issues addressed in the new ethical guidelines on the use of ART.
In July 2017, the TGA sought comments from interested parties to further align Australian and European medical device regulatory requirements to...
Sparke Helmore Lawyers
A string of successful prosecutions by the Food Authority should alert businesses to comply with food safety obligations.
Ropes & Gray LLP
The China Food and Drug Administration (CFDA) has published its proposed amendment of the Medical Device Regulations (MDR), previously known as the State Council Order # 650, for public comments.
Ropes & Gray LLP
The China Food and Drug Administration (CFDA) published its proposed amendment of the Drug Administration Law (DAL) and the Drug Registration Rules (DRR) for public comments. This Alert summarizes the key changes.
Ropes & Gray LLP
In addition, the Final Policy attempts to strike a balance between the potentially conflicting interest of innovative and generic drug manufacturers.
McDermott Will & Emery
Hospitals in China differ greatly from those in the west with respect to their relationships with physicians and patients; but they also share some of the same legal challenges faced by western hospitals.
Ropes & Gray LLP
In China, medical devices are divided into three regulatory classes based on the identified risks associated with the devices.
Ropes & Gray LLP
On May 19, 2017, China's State Council promulgated the amendments to the 2014 Regulation on the Supervision and Administration of Medical Devices ("the Amendments"), which became effective immediately.
Global Advertising Lawyers Alliance (GALA)
The Tribunal made an award on Jurisdiction and Admissibility in which it addressed only the three bifurcated objections raised by the Australian government.
Nishith Desai Associates
Nishith Desai Associates is a research-based Indian law firm with offices in Mumbai, Silicon Valley, Bangalore, Singapore, Mumbai BKC, Delhi and Munich that aims at providing strategic, legal and tax services...
Nishith Desai Associates
On November 1, 2017, India's central medical device regulator, the Central Drugs Standards Control Organization, published a revised risk classification of medical devices and IVDs...
Singh & Associates
An ePharmacy is an online pharmacy, Internet pharmacy or mail-order pharmacy that operates over the Internet and sends the orders to customers through the mail or shipping companies.
Rajeshwari & Associates
Internet has silently crept into our lives to an extent that not just household items, but drugs and other wellness products can be purchased online easily.
Khaitan & Co
The healthcare industry in India has seen an impressive growth trajectory in the past few years and the Indian medical devices market has been the sunrise segment in the healthcare space.
Clyde & Co
India is at the cusp of establishing a robust and organized food sector. Many global players such as Amazon (USA), Nestle (Switzerland), Unilever (United Kingdom) and Yakult (Japan) are playing a key role...
Clyde & Co
This edition brings to our readers a featured article titled "Foreign Investment in the Food Sector – the Present and the Road Ahead".
E-pharmacies or online pharmacies have been a subject matter of debate in India for the last 3-4 years. Their offline counterparts have been lobbying to get a blanket ban on any online sale of drugs, whether prescription or over-the-counter.
Nishith Desai Associates
After the recent move to fix the price of the coronary stents, the Indian government has imposed a price ceiling on knee replacement systems for a period of one year by way of a notification dated August 17, 2017.
Remfry & Sagar
Trastuzumab - a breast cancer drug manufactured by Roche and Genentech Inc., is imported and marketed in India by Roche Products (India) Private Limited under the brand names Herceptin, Herclon and Biceltis.
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Australia
Businesses in food and agriculture industries should be particularly alive to the risk of slavery in their supply chains.
Holman Webb
A genomic profile may help a doctor make personalised health decisions, but also raises a number of ethical challenges.
Carroll & O'Dea
The appeal addressed how the trial judge could properly choose between competing expert opinions on mental harm.
Norton Rose Fulbright Australia
The article considers the responses to some of the key recommendations and potential implications of these responses.
Holman Webb
Future action for non-compliance with the ACL in the marketing of therapeutic goods may result in much higher penalties.
Holman Webb
The Appeal decision confirms the need to understand medical malpractice and civil liability policy terms and conditions.
Carroll & O'Dea
Despite the popularity of cosmetic procedures, the industry in Australia is less regulated than other areas of medicine.
Clayton Utz
These proposed changes to the Therapeutic Goods Advertising Code are intended to promote four clear objectives.
Holman Webb
When the treatment rendered is consistent, consent will not be vitiated if a different surgeon performs the procedure.
Corrs Chambers Westgarth
This article is an overview of key proposed IP changes, the likely impact and five takeaways for your organisation.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Font Size:
Mondaq on Twitter